Clinical Trial Details
| Trial ID: | L3273 |
| Source ID: | NCT04972539 |
| Associated Drug: | Aju-A51 Tab. |
| Title: | Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: AJU-A51 Tab.|DRUG: A51R1 Tab. and A51R2 Tab. |
| Outcome Measures: | Primary: AUCt(Area Under Curve last) of AJU-A51, Area under the plasma concentration time curve of AJU-A51, predose, 0.17, 0.33, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 8, 12, 24, 48, 72hours post-dose|Cmax, The maximum concentration observed of AJU-A51 over blood sampling time., predose, 0.17, 0.33, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 8, 12, 24, 48, 72hours post-dose | |
| Sponsor/Collaborators: | Sponsor: AJU Pharm Co., Ltd. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 48 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2020-08-01 |
| Completion Date: | 2021-03-09 |
| Results First Posted: | |
| Last Update Posted: | 2021-07-22 |
| Locations: | Jang Hee Hong, Daejeon, Korea, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT04972539 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|